Glaukos, which sells micro-scale surgical devices for treating glaucoma, filed on Tuesday with the SEC to raise up to $86 million in an initial public offering.
The Laguna Hills, CA-based company, which was founded in 1998 and booked $46 million in sales for the 12 months ended December 31, 2014, plans to list on the NYSE under the symbol GKOS. Glaukos initially filed confidentially on July 23, 2014. J.P. Morgan, BofA Merrill Lynch and Goldman Sachs are the joint bookrunners on the deal. No pricing terms were disclosed.
